...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!

,,Hummmm,,after watching both companies spin their wheels for years and years and years and fail at every opportunity to create shareholder value it begs the question is it incompetence or is the team actually interested in getting their science across the finish line in real time?....the lack of performance extends the time line for continued funding of personal accounts. No business head in either company. As Buffet noted when investing,,,always buy the management team in your investment,,,,the track record and their history of success is absolutley essential to shareholders for creating value. He was spot on then and contiues to be on the mark! jmo

Share
New Message
Please login to post a reply